(Q42700019)

5 November 2017

Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V-->I) of the reverse transcriptase (English)

1 reference

Human T-lymphotropic virus 1

5 November 2017

1 reference

1 reference

1 reference

1 reference

Vincent Soriano

4

0 references

author name string

Carlos Toro

series ordinal

1

1 reference

5 November 2017

Berta Rodés

series ordinal

2

1 reference

5 November 2017

Carmen de Mendoza

series ordinal

3

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Antimicrobial Agents and Chemotherapy

5 November 2017

1 reference

5 November 2017

47

1 reference

5 November 2017

5

1 reference

5 November 2017

1774;author reply 1774-5

1 reference

Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

Mechanisms of resistance to antiretroviral drugs--clinical implications.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

The effect of antiretroviral therapy on HTLV infection

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153342

10.1128/AAC.47.5.1774-1775.2003

16 August 2018

Identifiers

DOI

1 reference

release_ercq2emaobfr5cigals2p6dfom

5 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ercq2emaobfr5cigals2p6dfom

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

5 November 2017

PubMed publication ID

12709359

1 reference